B. Riley Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
HCM
AAMU
FWCM
AAIS
B. Riley Wealth Advisors's ABBV Position: Q2 2026 in Review
B. Riley Wealth Advisors increased its AbbVie (ABBV) stake by 4.2% in Q2 2026, buying an estimated $281K and bringing the position to 32,220 shares worth $8.19M. The position accounts for 0.44% of the portfolio, ranked #49.
B. Riley Wealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.8M in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- B. Riley Wealth Advisors held 32,220 shares of AbbVie worth $8.19M as of Q2 2026.
- B. Riley Wealth Advisors bought 1,308 AbbVie shares in Q2 2026, an estimated $281K.
- AbbVie made up 0.44% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #49 holding.
- B. Riley Wealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- B. Riley Wealth Advisors's AbbVie position peaked at $30.8M in Q4 2022.
- 1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.